The value of image-guided intensity-modulated radiotherapy in challenging clinical settings

British Journal of Radiology

Volumn 86, Issue 1021, 2013, Pages

  Treece, S J ^a   Mukesh, M ^a   Rimmer, Y L ^a   Tudor, S J ^a   Dean, J C ^a   Benson, R J ^a   Gregory, D L ^a   Horan, G ^a   Jefferies, S J ^a   Grussell, S ^a   Williams, M V ^a   Wilson, C B ^a   Burnet, Neil G ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CARCINOMA; EWING SARCOMA; FEMALE; HUMAN; IMAGE GUIDED INTENSITY MODULATED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LARGE CELL LYMPHOMA; LARYNX CARCINOMA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; ORGANS AT RISK; PROSTATE ADENOCARCINOMA; RECTUM CARCINOMA; UTERINE CERVIX CARCINOMA; ADOLESCENT; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; IMAGE GUIDED RADIOTHERAPY; METHODOLOGY; MIDDLE AGED; NEOPLASM; RADIOGRAPHY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871906552     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20120278     Document Type: Article

References (51)

1. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-91. (Pubitemid 44633504)
2. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, et al Breast Technology Group. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007;82:254-64. (Pubitemid 46341474)
3. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008;9:367-75. (Pubitemid 351411653)
4. Staffurth J. A review of the clinical evidence for intensity modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010;22:643-57.
5. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36.
6. Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, et al. Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 2012;82:715-23.
7. Bujold A, Craig T, Jaffray D, Dawson LA. Image-guided radiotherapy: has it influenced patient outcomes? Semin Radiat Oncol 2012;22:50-61.
8. BIR Working Party. Geometric uncertainties in radiotherapy - defining the planning target volume. London, UK: British Institute of Radiology; 2003.
9. Royal College of Radiologists, Society and College of Radiographers, Institute of Physics and Engineering in Medicine. On target: ensuring geometric accuracy in radiotherapy. London, UK: Royal College of Radiologists; 2008.
10. Rimmer YL, Burnet NG, Routsis DS, Twyman N, Hoole AC, Treeby J, et al. Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK department. Clin Oncol (R Coll Radiol) 2008;20:22-30.
11. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007;25:938-46. (Pubitemid 350002859)
12. Verellen D, De Ridder M, Storme G. A (short) history of image-guided radiotherapy. Radiother Oncol 2008;86:4-13.
13. Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007;7:949-60. (Pubitemid 350165868)
14. Engels B, Soete G, Verellen D, Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys 2009;74:388-91.
15. Williams MV, Cooper T, Mackay R, Staffurth J Routsis D, Burnet NG. The implementation of intensity-modulated radiotherapy in the UK. Clin Oncol (R Coll Radiol) 2010;22:623-8.
16. Mayles WPM, Cooper T, Mackay R, Staffurth J, Williams M. Progress with intensity-modulated radiotherapy implementation in the UK. Clin Oncol (R Coll Radiol) 2012;24:543-4.
17. Sterzing F, Schubert K, Sroka-Perez G, Kalz J, Debus J, Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008;184:8-14.
18. Burnet NG, Adams EJ, Fairfoul J, Tudor GSJ, Hoole ACF, Routsis DS, et al. Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy. Clin Oncol (R Coll Radiol) 2010;22:294-312.
19. Giraud P, Kantor G, Yassa M, Zefkili S, Dejean C, Lisbona A, et al. Two-year clinical experience with tomotherapy: the French national cancer institute project on implementing new technology. Cancer Invest 2011;29:557-63.
20. Ting JY, Scarbrough TJ. Intensity-modulated radiation therapy and image-guided radiation therapy: small clinic implementation. Hematol Oncol Clin North Am 2006;20:63-86.
21. Welsh JS, Lock M, Harari PM, Tomé WA, Fowler J, Mackie TR, et al. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat 2006;5:465-79. (Pubitemid 44606268)
22. Whitton A, Warde P, Sharpe M, Oliver TK, Bak K, Leszczynski K, et al. Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol (R Coll Radiol) 2009;21:192-203.
23. Smith D, MacDougall N, Monk J, Sibtain A, Powell ME, Plowman PN. First quinquennial review of intensity-modulated radiotherapy at St Bartholomew's Hospital, London. Clin Oncol (R Coll Radiol) 2010;22:666-74.
24. Chatterjee S, Mott JH, Smyth G, Dickson S, Dobrowsky W, Kelly CG. Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre. Br J Radiol 2011;84:358-66.
25. Yartsev S, Kron T, Van Dyk J. Tomotherapy as a tool in image-guided radiation therapy (IGRT): theoretical and technological aspects. Biomed Imaging Interv J 2007;3:e16.
26. Houghton F, Benson RJ, Tudor GS, Fairfoul F, Gemmill J, Dean JC, et al. An assessment of action levels in imaging strategies in head and neck cancer using TomoTherapy. Are our margins adequate in the absence of image guidance? Clin Oncol (R Coll Radiol) 2009;21:720-7.
27. Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat 2008;110:411-16. (Pubitemid 351962592)
28. Li XA, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson B, et al. Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. Int J Radiat Oncol Biol Phys 2007;68:581-91. (Pubitemid 46694164)
29. ClinicalTrials.gov [homepage on the internet]. Washington D.C.: National Institute of Health; 1997 [cited October 2011]. Available from: http://www.clinicaltrials.gov
30. Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, et al. Neoadjuvant capecitibine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a Phase 2 trial. Lancet Oncol 2010;11:241-8.
31. Khoo VS, Dearnaley DP. Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer-the CHHiP trial. Clin Oncol (R Coll Radiol) 2008;20:12-14.
32. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 2010;76(Suppl. 3):S42-9.
33. Kian Ang K, Guo-Liang J, Feng Y, Clifton Stephens L, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. J Radiat Oncol Biol Phys 2001;50:1013-20. (Pubitemid 32594840)
34. Rutz HP, Weber DC, Sugahara S, Timmermann B, Lomax AJ, Bolsi A, et al. Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys 2007;67:512-20. (Pubitemid 46108303)
35. nhs.uk [homepage on the internet]. London, UK: NHS Specialised Services [cited March 2012]. Available from: http://www.specialisedservices.nhs.uk/info/ proton-beam-therapy
36. Potluri S, Jefferies SJ, Jena R, Harris F, Burton KE, Prevost AT, et al. Residual post-operative tumour volume predicts outcome after high dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine. Clin Oncol (R Coll Radiol) 2011;23:199-208.
37. rcog.org.uk [homepage on the internet]. London, UK: Royal College of Physicians, Royal College of Radiologists and Royal College of Obstetricians and Gynaecologists; 2007 [cited October 2011]. Available from: http://www.rcog.org. uk/womens-health/clinical-guidance/effects-cancer-treatment-reproductive- function-guidance-management
38. Burnet NG, Bliss JM, Harmer CL. The impact of radiotherapy dose on local control of Ewings sarcoma of bone. Sarcoma 1997;1:31-8. (Pubitemid 127700148)
39. Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC. Dose response and local control using radiotherapy in nonmetastatic Ewing sarcoma. Pediatr Blood Cancer 2007;49:145-8. (Pubitemid 47041103)
40. Kirby R, Burnet N, Routsis D, Lenane M. A case of postoperative breast irradiation on a patient with pectus excavatum. Synergy Imaging & Therapy Practice, [serial on the internet]. October 2009 [citedMarch 2012];24:[4 pp.]. Available from: http://content.yudu.com/Library/A1gr1e/SynergyMImagingTherap/ resources/8.htm
41. Stroup SP, Cullen J, Auge BK, L'Esperance JO, Kang SK. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group - American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix Consensus Definition. Cancer 2007;110:1003-9. (Pubitemid 47312865)
42. Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Adamovich E. Obesity is not predictive of overall survival following permanent prostate brachytherapy. Am J Clin Oncol (R Coll Radiol) 2007;30:588-96. (Pubitemid 350307183)
43. Wong JR, Zhanrong G, Merrick S, Wilson P, Uematsu M, Woo K, et al. Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocentres in an analysis of 1465 computed tomographic images. Int J Radiat Oncol Biol Phys 2009;75:49-55.
44. Hanna CL, Slade S, Mason MD, Burnet NG. Translating radiotherapy clinical target volumes into planning target volumes for bladder and brain tumour patients. Clin Oncol (R Coll Radiol) 1999;11:93-8.
45. Sulman EP, Schwartz DL, Thuy TL, Kian Ang K, Morrison WH, Rosenthal D, et al. IMRT reirradiation of head and neck cancer - disease control and morbidity outcomes. J Radiat Oncol Biol Phys 2009;73:399-409.
46. Chua DTT, Sham JST, Leung LHT, Au GKH. Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol 2005;77:290-4. (Pubitemid 41785339)
47. Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys 2005;61:450-5. (Pubitemid 40164440)
48. Kim YS, Kim JH, Ahn SD, Lee S-W, Shin SS, Nam J-H, et al. High-dose extended-field irradiation and high-dose rate brachytherapy with concurent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2009;74:1522-8.
49. Ares C, Hug EB, Lomax AJ, Bolsi A, Timmermann B, Rutz HP, et al. Effectiveness and safety of spot scanning proton radiotherapy for chordomas and chondrosarcomas of the skull base: first long term report. J Radiat Oncol Biol Phys 2009;75:1111-18.
50. Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Dean S, Yeap BY, et al. Phase II study of high dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2009;74:732-9.
51. Foweraker KL, Burton KE, Maynard SE, Jena R, Jefferies SJ, Laing RJ, et al. Skull base surgery and neurosurgery collaborators. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: Part 1 - clinical outcomes. Clin Oncol (R Coll Radiol) 2007;19:509-16. (Pubitemid 47181180)